Bifogade filer
PM-Emplicure AR2022-ENG-2023-05-23.pdf
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
The 2022 Annual report of Emplicure AB (publ) is now available on the Company's website.
The annual report is available in PDF format on the Company's website at:
https://investor.emplicure.com/financial-reports/annual-reports/
Printed copies of the annual report can be ordered from Emplicure AB, Virdings allé 32B, SE-754 50 Uppsala, or by e-mail: info@emplicure.com.
For additional information, please contact
Håkan Engqvist
CEO
Phone: +46 702 569 500
Email: hakan.engqvist@emplicure.com
Erik Magnusson
CFO
Phone: +46 708 565 245
Email: erik.magnusson@emplicure.com
Certified Adviser
Emplicure AB (publ) is listed on the Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank.
The following documents can be retrieved from beQuoted
PM-Emplicure AR2022-ENG-2023-05-23.pdf
Emplicure-AR-2022 ENG.pdf
Emplicure develops new and innovative products by combining existing and approved active substances with advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain and on abuse-deterrent formulations. The subsidiary Amplicon AB develops consumer products with oral nicotine as the first product. The share is listed on Nasdaq First North Growth Market (EMPLI). Read more at www.emplicure.com